Literature DB >> 34984767

Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1.

Daniel V Schiavone1,2, Diana M Kapkayeva1, Qilan Li3, Molly E Woodson3, Andreu Gazquez Casals3, Lynda A Morrison3, John E Tavis3, Ryan P Murelli1,2.   

Abstract

Polyoxygenated tropolones possess a broad range of biological activity, and as a result are promising lead structures or fragments for drug development. However, structure-function studies and subsequent optimization have been challenging, in part due to the limited number of readily available tropolones and the obstacles to their synthesis. Oxidopyrylium [5+2] cycloaddition can effectively generate a diverse array of seven-membered ring carbocycles, and as a result can provide a highly general strategy for tropolone synthesis. Here, we describe the use of 3-hydroxy-4-pyrone-based oxidopyrylium cycloaddition chemistry in the synthesis of functionalized 3,7-dimethoxytropolones, 3,7-dihydroxytropolones, and isomeric 3-hydroxy-7-methoxytropolones through complementary benzyl alcohol-incorporating procedures. The antiviral activity of these molecules against herpes simplex virus-1 and hepatitis B virus is also described, highlighting the value of this approach and providing new structure-function insights relevant to their antiviral activity.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  hepatitis B antivirals; herpes simplex virus antivirals; oxidopyrylium cycloaddition; structure-function analysis; tropolones

Mesh:

Substances:

Year:  2022        PMID: 34984767      PMCID: PMC8858858          DOI: 10.1002/chem.202104112

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  42 in total

Review 1.  HBV replication inhibitors.

Authors:  Claire Pierra Rouviere; Cyril B Dousson; John E Tavis
Journal:  Antiviral Res       Date:  2020-05-05       Impact factor: 5.970

2.  Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.

Authors:  Peter J Ireland; John E Tavis; Michael P D'Erasmo; Danielle R Hirsch; Ryan P Murelli; Mark M Cadiz; Bindi S Patel; Ankit K Gupta; Tiffany C Edwards; Maria Korom; Eileen A Moran; Lynda A Morrison
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones.

Authors:  Alex J Berkowitz; Abaigeal D Franson; Andreu Gazquez Cassals; Katherine A Donald; Alice J Yu; Aswin K Garimallaprabhakaran; Lynda A Morrison; Ryan P Murelli
Journal:  Medchemcomm       Date:  2019-05-30       Impact factor: 3.597

4.  Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.

Authors:  Christine Johnston; Misty Saracino; Steve Kuntz; Amalia Magaret; Stacy Selke; Meei-Li Huang; Joshua T Schiffer; David M Koelle; Lawrence Corey; Anna Wald
Journal:  Lancet       Date:  2012-01-04       Impact factor: 79.321

5.  Synthesis and characterization of a novel inhibitor of an aminoglycoside-inactivating enzyme.

Authors:  H A Kirst; G G Marconi; F T Counter; P W Ensminger; N D Jones; M O Chaney; J E Toth; N E Allen
Journal:  J Antibiot (Tokyo)       Date:  1982-12       Impact factor: 2.649

6.  Amidation Strategy for Final-Step α-Hydroxytropolone Diversification.

Authors:  Alex J Berkowitz; Rudolf G Abdelmessih; Ryan P Murelli
Journal:  Tetrahedron Lett       Date:  2018-06-30       Impact factor: 2.415

7.  Broad anti-herpesviral activity of α-hydroxytropolones.

Authors:  Shannon D Dehghanpir; Claire H Birkenheuer; Kui Yang; Ryan P Murelli; Lynda A Morrison; Stuart F J Le Grice; Joel D Baines
Journal:  Vet Microbiol       Date:  2017-12-27       Impact factor: 3.293

8.  Investigations into a Stoichiometrically Equivalent Intermolecular Oxidopyrylium [5 + 2] Cycloaddition Reaction Leveraging 3-Hydroxy-4-pyrone-Based Oxidopyrylium Dimers.

Authors:  Daniel V Schiavone; Diana M Kapkayeva; Ryan P Murelli
Journal:  J Org Chem       Date:  2021-02-15       Impact factor: 4.354

Review 9.  Recent Advances in Hepatitis B Treatment.

Authors:  Georgia-Myrto Prifti; Dimitrios Moianos; Erofili Giannakopoulou; Vasiliki Pardali; John E Tavis; Grigoris Zoidis
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

10.  Free Energy-Based Virtual Screening and Optimization of RNase H Inhibitors of HIV-1 Reverse Transcriptase.

Authors:  Baofeng Zhang; Michael P D'Erasmo; Ryan P Murelli; Emilio Gallicchio
Journal:  ACS Omega       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.